RA
PEPLW

Ramius Advisors’s PepperLime Health Acquisition Corporation Warrrant PEPLW Stock Holding History

Ramius Advisors’s Portfolio PEPLW Stock Details PEPLW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-93,525
Closed -$1.43K – 121
2022
Q4 		$1.43K Sell
93,525
-400
-0.4% -$12 ﹤0.01% 126
2022
Q3 		$8K Hold
93,925
– – ﹤0.01% 141
2022
Q2 		$24K Buy
+93,925
New +$38.4K 0.01% 119
2022
Q1 		– Sell
-31,018
Closed -$14K – 140
2021
Q4 		$14K Buy
+31,018
New +$14.7K ﹤0.01% 339

Other funds holding PEPLW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Ramius Advisors's PEPLW Position: Q1 2023 in Review

Ramius Advisors sold out of PepperLime Health Acquisition Corporation Warrrant (PEPLW) in Q1 2023, closing a stake of 93,525 shares — an estimated $1.43K sold.

Ramius Advisors first reported a position in PEPLW in Q4 2021 and held it in 4 quarters. The position peaked at $24K in Q2 2022. 23 funds tracked by Wall St. Rank hold PEPLW as of Q1 2023.

  • Ramius Advisors reported no remaining PepperLime Health Acquisition Corporation Warrrant position as of Q1 2023 after selling out during the quarter.
  • Ramius Advisors sold 93,525 PepperLime Health Acquisition Corporation Warrrant shares in Q1 2023, an estimated $1.43K.
  • Ramius Advisors first reported a position in PepperLime Health Acquisition Corporation Warrrant in Q4 2021 and held it in 4 quarters.
  • Ramius Advisors's PepperLime Health Acquisition Corporation Warrrant position peaked at $24K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Warrrant as of Q1 2023.

Based on Ramius Advisors's 13F filing for Q1 2023, filed 11 May 2023.